combination of amprenavir and ABT-378/r
Sep 1, 2000
Hi, my name is Edgardo. I am a doctor who works with HIV patients. I would like to know if you have any information about the dosage of amprenavir plus ABT378/r in combination. My little information says that the dosage of amprenavir must be reduced to 750 mg bid ¿is that correct?
I am waiting for your answer. Thank you.
Response from Dr. Pavia
Dear Doctor Bottaro,
Your question is a timely one. If you add ritonavir 100 mg bid to amprenavir, data from the world aids conference and other studies suggests that an amprenavir dose of 600 or perhaps 750 mg bid gives the best combination of increased cmin without too much increase in peak levels.
I am told that Abbott has just completed a preliminary study of amprenavir with ABT-378/r (to be marketed as Kaletra. I don't believe it will be presented until later in September. The amprenavir levels were not significantly boosted, suggesting a dose closer to the normal dose should be used. However, I think you should contact Abbott directly and request the information from them.
Andrew T. Pavia
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Five Ways Hiv Can Be Transmitted
- Can Hiv Be Transmitted By Sputum?
- Should A Person With Hepatitis C Be Working With Food?
- Can You Get Hiv From A Massage Therapist?
- Statistics Of Risk Of Hiv Following A Needlestick
- Can I Be Exposed To Hiv And Test Negative For Two Years Then Test Positive?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.